IMS Health to introduce a consumer version of its health app ratings app
CLEVELAND – IMS Health is getting ready to launch a consumer version of its professionally-geared AppScript app in May, MedCityNews reported earlier this week.
Currently, AppScript enables doctors to rate and “prescribe” mobile apps for their patients, MedCityNews noted. "Very early research suggests about half of the patients who get prescribed apps through AppScript will use them beyond the first month," MedCityNews reported citing IMS Health.
But now AppScript will be available "without a prescription," so to speak, allowing consumers to identify and download appropriate health apps to help them manage their conditions based on those doctor's ratings.
CRN urges consumers to heed FDA warning on Tri-Methyl Xtreme
SILVER SPRING, Md. – The U.S. Food and Drug administration earlier this week warned consumers to stop using a dietary supplement for muscle growth linked to serious liver injury.
Tri-Methyl Xtreme, distributed by Las Vegas-based Extreme Products Group, claims to contain anabolic steroids and is sold on the Internet and in some retail stores and gyms.
An investigation is underway by the FDA to identify the product’s manufacturer after the agency received adverse event reports from consumers — one each from California, New Jersey and Utah. The agency has not received reports of death from use of the product.
“We urge consumers to take seriously FDA’s consumer advisory urging people not to use a product for muscle growth that the agency has indicated is linked to serious liver injury. According to the agency, Tri-Methyl Xtreme, distributed by Las Vegas-based Extreme Products Group, claims to contain anabolic steroids, not permitted to be sold in a dietary supplement, making it an adulterated product," stated Steve Mister, president and CEO of the Council for Responsible Nutrition. "Clearly, products like these create a problem — for consumers, and for responsible industry — and our association is continuing to seek ways to support FDA to get these products off the market. At the very least, more robust and more frequent inspections of manufacturers under the existing good manufacturing practices regulations is required."
“Products marketed as supplements that contain anabolic steroids pose a real danger to consumers,” stated Charles Lee, a senior medical advisor in the FDA’s Center for Drug Evaluation and Research’s Office of Compliance. “Anabolic steroids may have a range of serious adverse effects on many organ systems, and the damage may be irreversible.”
Liver injury is generally known to be a possible outcome of using products that contain synthetic anabolic steroids, and steroid-like substances. In general, anabolic steroids may cause other serious long-term consequences, including adverse effects on cholesterol levels; increased risk of heart attack and stroke; masculinization of women; shrinkage of the testicles; breast enlargement; infertility in males; and short stature in children.
NBTY picks up wealth of CPG experience with new senior level executives
RONKONKOMA, N.Y. – NBTY on Thursday appointed four senior executives to its management team who will spearhead strategic growth initiatives for the company's branded businesses.
"NBTY's portfolio of brands is among the most well-known and trusted in the industry, and we're bringing in and promoting outstanding, experienced new talent that will drive our growth to the next level" stated Brian Wynne, president, NBTY Americas and CEO, US Nutrition. "These changes inject fresh thinking and perspective into the company while complementing our existing team of passionate and driven leaders."
Derek Bowen (pictured left) has been named SVP, general manager for vitamins, minerals, herbals and supplements. Bowen, who joins NBTY from Coty Beauty U.S., will be responsible for developing and executing strategic growth plans for all of NBTY's US Nutrition VMHS brands, including Nature's Bounty, Sundown Naturals, Osteo Bi-Flex and Ester-C, with full profit and loss accountability. As SVP marketing for Coty, Derek was responsible for managing volume and profit for the U.S. cosmetic and fragrance portfolios. Bowen has 20 years of experience in building and marketing well-known brands at consumer products companies such as Unilever, Sara Lee, Dial and P&G.
Bradley Charron (pictured right) was named SVP general manager for sports and active nutrition. Charron will be responsible for developing and executing strategic growth plans for all the company's sports and active nutrition brands, such as MET-Rx, Pure Protein, Body Fortress and Balance Bar, with full profit and loss accountability. Charron brings 15 years' experience with him to NBTY, most recently with Chobani, where he served as their SVP marketing. Prior to that, Charron held senior leadership positions with Under Armour, PepsiCo and Liz Claiborne.
Andre Branch has joined NBTY as chief marketing officer, where he will lead consumer and customer marketing efforts, as well as focus on strategies to further build NBTY's trusted and high-quality brands, including Nature's Bounty, Sundown Naturals, Ester-C, Solgar and Osteo Bi-Flex. This will include developing the strategy, building brand and product roadmaps and developing a robust innovation pipeline that leverages consumer data, shopper insights and various media platforms. Branch brings more than 20 years of brand-building experience to the role from companies including Kraft Foods, Diageo and, most recently, L'Oreal.
Additionally, the company has promoted Jill Staib into a newly created position, VP strategic initiatives and private label. In this role she will focus on identifying and capturing value from both operational and market based opportunities and executing plans for NBTY's private label business, among other things.
Loading Post Please Wait...